A new drug has been approved by the European Medicines Agency which could offer better treatment to patients with multiple sclerosis. Alemtuzumab will give people who have the disease the chance to live without the side effects for much longer.
Symptoms of the disease can include loss of physical skills, sensation, vision and bladder control.
Professor Herman Waldmann was involved in the early discovery work of the antibody drug called Campath-1H at Cambridge University. It was originally used to treat leukaemia. He continued to study the drug for two decades while at Oxford University.
More top news
Smoke once again fills the skies of Surrey after another fire breaks out in Pirbright. It's a continuation of the blaze on Wednesday.
Reading left nothing on the pitch in a valiant effort to reach the FA Cup final. An extra-time winner from Sanchez sealed the Royals' fate.
The latest weather update for the east with Philippa